Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system. View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-01

AUTHORS

A Iten, P Chatelard, P Vuadens, J Miklossy, R Meuli, R Sahli, P R Meylan

ABSTRACT

Over a 2 year period, we identified five HIV-infected patients who presented with central nervous system infection caused by varicella-zoster virus, three with myelitits, and two with meningoencephalitis. All five patients were profoundly immunocompromised. Clinical presentation of these patients overlapped to a significant extent with diseases caused by other viruses, e.g. CMV. Indeed, in one case, a dual infection with CMV was diagnosed, but the respective role of each virus was ascertained by in situ hybridisation. At the time of CNS involvement, only one patient had active VZV cutaneous lesions, which were instrumental in diagnosing her condition. In contrast, PCR for VZV DNA in the CSF was helpful in making a diagnosis in the four other cases, one of which was confirmed by a post mortem. Of these five patients, two patients developed VZV disease while receiving oral acyclovir and had foscarnet treatment initiated when MRI demonstrated widespread lesions. They did not respond to antiviral therapy. The three other patients had intravenous acyclovir initiated at a time when no or limited parenchymal lesions were observed by MRI. Two of these three patients had VZV infection diagnosed solely on the basis of PCR: all three responded to treatment. Our data show that reactivation of VZV involving the central nervous system occurs frequently in the absence of cutaneous lesions. PCR of cerebrospinal fluid may help in making an early diagnosis which is probably a prerequisite for successful treatment of VZV infection of the CNS. More... »

PAGES

172-80

Identifiers

URI

http://scigraph.springernature.com/pub.10.3109/13550289909021999

DOI

http://dx.doi.org/10.3109/13550289909021999

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1070986123

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10321981


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "AIDS-Related Opportunistic Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acyclovir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytomegalovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Foscarnet", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Herpes Zoster", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Herpesvirus 3, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunocompromised Host", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.", 
          "id": "http://www.grid.ac/institutes/grid.8515.9", 
          "name": [
            "Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iten", 
        "givenName": "A", 
        "id": "sg:person.01251407053.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251407053.33"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Chatelard", 
        "givenName": "P", 
        "type": "Person"
      }, 
      {
        "familyName": "Vuadens", 
        "givenName": "P", 
        "id": "sg:person.01137404177.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137404177.17"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Miklossy", 
        "givenName": "J", 
        "id": "sg:person.013144436204.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013144436204.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Meuli", 
        "givenName": "R", 
        "id": "sg:person.0676346750.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676346750.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Sahli", 
        "givenName": "R", 
        "id": "sg:person.0761360220.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761360220.49"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Meylan", 
        "givenName": "P R", 
        "id": "sg:person.01336350503.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1999-01", 
    "datePublishedReg": "1999-01-01", 
    "description": "Over a 2 year period, we identified five HIV-infected patients who presented with central nervous system infection caused by varicella-zoster virus, three with myelitits, and two with meningoencephalitis. All five patients were profoundly immunocompromised. Clinical presentation of these patients overlapped to a significant extent with diseases caused by other viruses, e.g. CMV. Indeed, in one case, a dual infection with CMV was diagnosed, but the respective role of each virus was ascertained by in situ hybridisation. At the time of CNS involvement, only one patient had active VZV cutaneous lesions, which were instrumental in diagnosing her condition. In contrast, PCR for VZV DNA in the CSF was helpful in making a diagnosis in the four other cases, one of which was confirmed by a post mortem. Of these five patients, two patients developed VZV disease while receiving oral acyclovir and had foscarnet treatment initiated when MRI demonstrated widespread lesions. They did not respond to antiviral therapy. The three other patients had intravenous acyclovir initiated at a time when no or limited parenchymal lesions were observed by MRI. Two of these three patients had VZV infection diagnosed solely on the basis of PCR: all three responded to treatment. Our data show that reactivation of VZV involving the central nervous system occurs frequently in the absence of cutaneous lesions. PCR of cerebrospinal fluid may help in making an early diagnosis which is probably a prerequisite for successful treatment of VZV infection of the CNS.", 
    "genre": "article", 
    "id": "sg:pub.10.3109/13550289909021999", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1114176", 
        "issn": [
          "1355-0284", 
          "1538-2443"
        ], 
        "name": "Journal of NeuroVirology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "central nervous system", 
      "VZV infection", 
      "cutaneous lesions", 
      "nervous system", 
      "varicella-zoster virus infection", 
      "central nervous system infection", 
      "reactivation of VZV", 
      "cerebrospinal fluid PCR", 
      "nervous system infection", 
      "management of HIV", 
      "varicella-zoster virus", 
      "oral acyclovir", 
      "intravenous acyclovir", 
      "CNS involvement", 
      "system infection", 
      "foscarnet treatment", 
      "clinical presentation", 
      "VZV disease", 
      "antiviral therapy", 
      "parenchymal lesions", 
      "VZV DNA", 
      "successful treatment", 
      "widespread lesions", 
      "virus infection", 
      "dual infection", 
      "early diagnosis", 
      "cerebrospinal fluid", 
      "patients", 
      "infection", 
      "lesions", 
      "HIV", 
      "acyclovir", 
      "virus", 
      "treatment", 
      "disease", 
      "diagnosis", 
      "MRI", 
      "basis of PCR", 
      "year period", 
      "PCR", 
      "situ hybridisation", 
      "meningoencephalitis", 
      "VZV", 
      "CMV", 
      "therapy", 
      "CNS", 
      "respective roles", 
      "CSF", 
      "cases", 
      "presentation", 
      "significant extent", 
      "involvement", 
      "reactivation", 
      "management", 
      "period", 
      "absence", 
      "role", 
      "time", 
      "contrast", 
      "fluid", 
      "DNA", 
      "hybridisation", 
      "extent", 
      "data", 
      "impact", 
      "prerequisite", 
      "basis", 
      "system", 
      "conditions"
    ], 
    "name": "Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.", 
    "pagination": "172-80", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1070986123"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.3109/13550289909021999"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10321981"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.3109/13550289909021999", 
      "https://app.dimensions.ai/details/publication/pub.1070986123"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_337.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.3109/13550289909021999"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.3109/13550289909021999'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.3109/13550289909021999'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.3109/13550289909021999'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.3109/13550289909021999'


 

This table displays all metadata directly associated to this object as RDF triples.

237 TRIPLES      20 PREDICATES      113 URIs      105 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.3109/13550289909021999 schema:about N0ae97b8cfeeb49858389471078756247
2 N169bb32f344946b5a106c67e3b0f201d
3 N1b6110ba509046aaa9d9d15dd5e8398c
4 N2094c95b1a5b422fa1d6178c03bfb253
5 N26c31f847d1e45febf3094d6c92558b9
6 N273d1b2ee53b4ddaaad8f3992bda2998
7 N60b60048c27b48799ff6fcda6c055f49
8 N74ea45f2ea664d28940c5db5b9d2dd30
9 Nb45f2677f5ae44dd987fe23371a1993b
10 Nb84ff05bb78849a09640cbd3d6595d60
11 Nb87e9d9f9a964b8d864889b658d80fe0
12 Nc1981d956d1e42aa91b0b66d24ed624b
13 Nc7e23edadd3b4cfba03006e4212200d5
14 Nd2b9d821747e42cca22c81113ed37ad8
15 Nd7243aa8613b441699b4c5898d77c66b
16 Necd23124daa0428d968e5df9595383bb
17 Needeb030430941909b016c094ec3ed9f
18 Nfca078e915274e35b559e0565c2634d0
19 anzsrc-for:11
20 anzsrc-for:1108
21 schema:author Nf5039286ebaa472b9667b63dae64b335
22 schema:datePublished 1999-01
23 schema:datePublishedReg 1999-01-01
24 schema:description Over a 2 year period, we identified five HIV-infected patients who presented with central nervous system infection caused by varicella-zoster virus, three with myelitits, and two with meningoencephalitis. All five patients were profoundly immunocompromised. Clinical presentation of these patients overlapped to a significant extent with diseases caused by other viruses, e.g. CMV. Indeed, in one case, a dual infection with CMV was diagnosed, but the respective role of each virus was ascertained by in situ hybridisation. At the time of CNS involvement, only one patient had active VZV cutaneous lesions, which were instrumental in diagnosing her condition. In contrast, PCR for VZV DNA in the CSF was helpful in making a diagnosis in the four other cases, one of which was confirmed by a post mortem. Of these five patients, two patients developed VZV disease while receiving oral acyclovir and had foscarnet treatment initiated when MRI demonstrated widespread lesions. They did not respond to antiviral therapy. The three other patients had intravenous acyclovir initiated at a time when no or limited parenchymal lesions were observed by MRI. Two of these three patients had VZV infection diagnosed solely on the basis of PCR: all three responded to treatment. Our data show that reactivation of VZV involving the central nervous system occurs frequently in the absence of cutaneous lesions. PCR of cerebrospinal fluid may help in making an early diagnosis which is probably a prerequisite for successful treatment of VZV infection of the CNS.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N2a1aba0147774efe9679a6189f8b4e5e
28 N8f8bf5761a4345edb258dd4a2ac0ce8e
29 sg:journal.1114176
30 schema:keywords CMV
31 CNS
32 CNS involvement
33 CSF
34 DNA
35 HIV
36 MRI
37 PCR
38 VZV
39 VZV DNA
40 VZV disease
41 VZV infection
42 absence
43 acyclovir
44 antiviral therapy
45 basis
46 basis of PCR
47 cases
48 central nervous system
49 central nervous system infection
50 cerebrospinal fluid
51 cerebrospinal fluid PCR
52 clinical presentation
53 conditions
54 contrast
55 cutaneous lesions
56 data
57 diagnosis
58 disease
59 dual infection
60 early diagnosis
61 extent
62 fluid
63 foscarnet treatment
64 hybridisation
65 impact
66 infection
67 intravenous acyclovir
68 involvement
69 lesions
70 management
71 management of HIV
72 meningoencephalitis
73 nervous system
74 nervous system infection
75 oral acyclovir
76 parenchymal lesions
77 patients
78 period
79 prerequisite
80 presentation
81 reactivation
82 reactivation of VZV
83 respective roles
84 role
85 significant extent
86 situ hybridisation
87 successful treatment
88 system
89 system infection
90 therapy
91 time
92 treatment
93 varicella-zoster virus
94 varicella-zoster virus infection
95 virus
96 virus infection
97 widespread lesions
98 year period
99 schema:name Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.
100 schema:pagination 172-80
101 schema:productId N37fa7fff42c04300b118a40a0ce325dc
102 N58c3b04a9d00467ab0677845571320a8
103 N62d02b4168db4e2b98eff106c8402ee1
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070986123
105 https://doi.org/10.3109/13550289909021999
106 schema:sdDatePublished 2022-12-01T06:23
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N4c545b8c2dd244c2b378dd78898f70d4
109 schema:url https://doi.org/10.3109/13550289909021999
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N06786f7a23b048a5842252d98162b1f9 rdf:first sg:person.013144436204.44
114 rdf:rest N509966ad9f9d4a988f3c352d96f4f09c
115 N0ae97b8cfeeb49858389471078756247 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Acyclovir
117 rdf:type schema:DefinedTerm
118 N169bb32f344946b5a106c67e3b0f201d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Foscarnet
120 rdf:type schema:DefinedTerm
121 N1b6110ba509046aaa9d9d15dd5e8398c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N2094c95b1a5b422fa1d6178c03bfb253 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Herpesvirus 3, Human
126 rdf:type schema:DefinedTerm
127 N26c31f847d1e45febf3094d6c92558b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Middle Aged
129 rdf:type schema:DefinedTerm
130 N273d1b2ee53b4ddaaad8f3992bda2998 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 N2a1aba0147774efe9679a6189f8b4e5e schema:volumeNumber 5
134 rdf:type schema:PublicationVolume
135 N2f80fc8c88ff4dde8c6c9f77d4c5227c rdf:first sg:person.01336350503.09
136 rdf:rest rdf:nil
137 N3571709abcf1480b8de543288354e5e3 rdf:first sg:person.01137404177.17
138 rdf:rest N06786f7a23b048a5842252d98162b1f9
139 N37fa7fff42c04300b118a40a0ce325dc schema:name pubmed_id
140 schema:value 10321981
141 rdf:type schema:PropertyValue
142 N4c545b8c2dd244c2b378dd78898f70d4 schema:name Springer Nature - SN SciGraph project
143 rdf:type schema:Organization
144 N509966ad9f9d4a988f3c352d96f4f09c rdf:first sg:person.0676346750.55
145 rdf:rest Nc2f2adc7f58c4ff888553f55f8f8ecee
146 N58c3b04a9d00467ab0677845571320a8 schema:name dimensions_id
147 schema:value pub.1070986123
148 rdf:type schema:PropertyValue
149 N60b60048c27b48799ff6fcda6c055f49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Polymerase Chain Reaction
151 rdf:type schema:DefinedTerm
152 N62bb197c2c664b1faa0da99df453554a rdf:first Nb10b40daefb94da7bc2f3951db2d6cf5
153 rdf:rest N3571709abcf1480b8de543288354e5e3
154 N62d02b4168db4e2b98eff106c8402ee1 schema:name doi
155 schema:value 10.3109/13550289909021999
156 rdf:type schema:PropertyValue
157 N74ea45f2ea664d28940c5db5b9d2dd30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name HIV Infections
159 rdf:type schema:DefinedTerm
160 N8f8bf5761a4345edb258dd4a2ac0ce8e schema:issueNumber 2
161 rdf:type schema:PublicationIssue
162 Nb10b40daefb94da7bc2f3951db2d6cf5 schema:familyName Chatelard
163 schema:givenName P
164 rdf:type schema:Person
165 Nb45f2677f5ae44dd987fe23371a1993b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Cytomegalovirus
167 rdf:type schema:DefinedTerm
168 Nb84ff05bb78849a09640cbd3d6595d60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name In Situ Hybridization
170 rdf:type schema:DefinedTerm
171 Nb87e9d9f9a964b8d864889b658d80fe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Female
173 rdf:type schema:DefinedTerm
174 Nc1981d956d1e42aa91b0b66d24ed624b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Immunocompromised Host
176 rdf:type schema:DefinedTerm
177 Nc2f2adc7f58c4ff888553f55f8f8ecee rdf:first sg:person.0761360220.49
178 rdf:rest N2f80fc8c88ff4dde8c6c9f77d4c5227c
179 Nc7e23edadd3b4cfba03006e4212200d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name AIDS-Related Opportunistic Infections
181 rdf:type schema:DefinedTerm
182 Nd2b9d821747e42cca22c81113ed37ad8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Adult
184 rdf:type schema:DefinedTerm
185 Nd7243aa8613b441699b4c5898d77c66b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Antiviral Agents
187 rdf:type schema:DefinedTerm
188 Necd23124daa0428d968e5df9595383bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name DNA, Viral
190 rdf:type schema:DefinedTerm
191 Needeb030430941909b016c094ec3ed9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Central Nervous System Infections
193 rdf:type schema:DefinedTerm
194 Nf5039286ebaa472b9667b63dae64b335 rdf:first sg:person.01251407053.33
195 rdf:rest N62bb197c2c664b1faa0da99df453554a
196 Nfca078e915274e35b559e0565c2634d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Herpes Zoster
198 rdf:type schema:DefinedTerm
199 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
200 schema:name Medical and Health Sciences
201 rdf:type schema:DefinedTerm
202 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical Microbiology
204 rdf:type schema:DefinedTerm
205 sg:journal.1114176 schema:issn 1355-0284
206 1538-2443
207 schema:name Journal of NeuroVirology
208 schema:publisher Springer Nature
209 rdf:type schema:Periodical
210 sg:person.01137404177.17 schema:familyName Vuadens
211 schema:givenName P
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137404177.17
213 rdf:type schema:Person
214 sg:person.01251407053.33 schema:affiliation grid-institutes:grid.8515.9
215 schema:familyName Iten
216 schema:givenName A
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251407053.33
218 rdf:type schema:Person
219 sg:person.013144436204.44 schema:familyName Miklossy
220 schema:givenName J
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013144436204.44
222 rdf:type schema:Person
223 sg:person.01336350503.09 schema:familyName Meylan
224 schema:givenName P R
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09
226 rdf:type schema:Person
227 sg:person.0676346750.55 schema:familyName Meuli
228 schema:givenName R
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676346750.55
230 rdf:type schema:Person
231 sg:person.0761360220.49 schema:familyName Sahli
232 schema:givenName R
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761360220.49
234 rdf:type schema:Person
235 grid-institutes:grid.8515.9 schema:alternateName Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
236 schema:name Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
237 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...